A controlled release or delayed release formulation contains a selective serotonin reuptake inhibitor (SSRI) such as paroxtine.

 
Web www.patentalert.com

< Surgically implanted time release medication for post-surgical treatment of a patient

< Target cell-specific adenoviral vectors containing E3 and methods of use thereof

> Prolonged efficacy of islet neogenesis therapy methods with a gastrin/CCK receptor ligand and an EGF receptor ligand composition in subjects with preexisting diabetes

> Preparation of lactic acid from a pentose-containing substrate
~ 00223